Erin T. Langan

Erin T. Langan

Auto-generated profile, based on publicly available information

Erin T. Langan

New England Center for Stroke Research, Department of Radiology, University of Massachusetts Medical School, Worcester, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2019 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
APAnne-Laure Papa
Anne-Laure Papa
AJAmanda Jiang
Amanda Jiang
NKNetanel Korin
Netanel Korin
MCMichelle B. Chen
Michelle B. Chen
ELErin T. Langan
Erin T. Langan
DIDonald E Ingber
Donald E Ingber
Human platelet decoys prevented thrombosis in rabbits and inhibited cancer cell aggregation and extravasation in vitro and in a mouse model.

8 May 2020 in CardioVascular and Interventional Radiology
Verified
Journal Article
Open access
PDF file
RKRobert M. King
Robert M. King
ELErin T. Langan
Erin T. Langan
GUGiovanni J. Ughi
Giovanni J. Ughi
CRChristopher M. Raskett
Christopher M. Raskett
APAjit S. Puri
Ajit S. Puri
MGMatthew J Gounis
Matthew J Gounis
Purpose The implantation of flow diverters requires administration of dual anti-platelet therapy, posing the potential for complications. The p48MW HPC (phenox, Bochüm, Germany) hydrophilic-coated flow diverting stent is designed to be anti-thrombotic, thus opening the potential for single anti-platelet therapy. We deploy a novel intravascular high-resolution imaging technique, high-frequency optical coherence tomography (HF-OCT), to study in an animal model the acute thrombus formation on coated p48MW devices versus uncoated control devices. Methods Three pigs were implanted with 4 flow diverters each, two test hydrophilic-coated devices, and two control uncoated devices (p48MW). Each pig was treated with a different anti-platelet regime: no anti-platelet therapy, aspirin only, aspirin and clopidogrel. Twenty minutes after the flow diverter was implanted, an HF-OCT data set was acquired. Acute clot formed on the flow diverter at each covered side branch was measured from the HF-OCT slices. Factors considered to be important were the device type (pHPC versus bare metal), aspirin, clopidogrel, and vessel location. A linear model was constructed from the significant factors. Results Both coating (p < 0.001) and aspirin (p = 0.003) were significantly related to reduction in clot burden, leading to an approximate 100-fold and 50-fold reduction in clot, respectively. Conclusions This study shows the power of HF-OCT not only in the detection of clot but also the quantification of clot burden. In an animal model, the pHPC-coated p48MW significantly reduced acute thrombus formation over jailed side branches as compared to the bare metal p48MW that was nearly eliminated when combined with aspirin administration.